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A B S T R A C T
Beagles are commonly used in vaccine trials as part of the regulatory approval process. Genetic restric-
tion within this breed and the impact this might have on vaccine responses are rarely considered. This
study was designed to characterise diversity of dog leucocyte antigen (DLA) class II genes in a breeding
colony of laboratory Beagles, whose offspring are used in vaccine studies. DLA haplotypes were deter-
mined by PCR and sequence-based typing from genomic DNA extracted from blood. Breeding colony Beagles
had significantly different DLA haplotype frequencies in comparison with pet Beagles and both groups
showed limited DLA diversity. Restricted DLA class II genetic variability within Beagles might result in
selective antigen presentation and vaccine responses that are not necessarily representative of those seen
in other dog breeds.
© 2014 The Authors. Published by Elsevier Ltd. This is an open access article under the CC BY license
(http://creativecommons.org/licenses/by/4.0/).
Vaccine efficacy is fundamental to ensuring protection of animals
against infectious disease and inmaintaining herd immunity. Beagles
are used for vaccine trials, designed to provide evidence of effica-
cy for regulatory approval. However, dog breeds, including the Beagle,
have been derived from at least two genetic bottlenecks
(Lindblad-Toh et al., 2005), which might affect their immunoge-
netic diversity and vaccine responses. Vaccination induced antibody
titres can vary with breed, although genetic factors have yet to be
identified (Kennedy et al., 2007b).
Dog leucocyte antigen (DLA) class II genes encode major histo-
compatibility complex (MHC) molecules that are involved in antigen
presentation to CD4+ T cells. In dogs, these consist of three, highly
polymorphic, loci, DLA-DRB1, DLA-DQA1 and DLA-DQB1 (Wagner,
2003). There is a large degree of inter-breed variability, but often
limited intra-breed diversity, of DLA haplotypes (Kennedy et al.,
2002a). The aim of the present study was to characterise DLA
haplotypes in laboratory Beagle dogs and to compare their DLA di-
versity with a pet Beagle population.
Residual blood samples were obtained from laboratory Beagles
(n = 100) in a commercial breeding facility, that provided puppies
for vaccine trials in Europe; sampleswere collected for another study
(project number114-C-E-01-10; date of Animal Care andEthics Com-
mittee approval 7 June2010). Blood samples frompetBeagles (n = 47)
were obtained from the Royal Veterinary College genetic archive,
containing residual samples followingcompletionof diagnostic testing
with informed owner consent and with approval in 2004 from the
institutional Ethics andWelfare Committee. Forty-eight pet Beagles,
previously genotyped at theUniversity ofManchester (date of Animal
Care and Ethics Committee approval April 2004)were also analysed
and included in the pet Beagle group. Information on pedigrees and
relatedness of the dogs was not available.
Genomic DNA was extracted using the GenElute Blood Genomic
DNA Kit (Sigma-Aldrich). PCRwas performed in 25 μL reactions, with
1 μL DNA as template, DLA-specific primers (2 μL at 20 pmol/μL final
concentration; Sigma-Aldrich) (see Appendix: Supplementary
Table S1), 5 μL Hi-Spec additive, 2.5 μL ImmoBuffer, 1.25 μL MgCl2
(2.5 mM final concentration), 0.25 μL deoxynucleotide triphos-
phates (1mMfinal total concentration) and 0.1 μL (1.25 IU) Immolase
DNA polymerase (Bioline). PCR was performed using a G-Storm GS1
Thermal Cycler (Gene Technologies) at 95 °C for 10 min, followed
by 35 cycles of 94 °C for 40 s, 55 °C for 30 s for DQA1 or 60 °C for
DRB1 and DQB1, and 72 °C for 1min, then 72 °C for 10min. PCR prod-
ucts were processed using the GenElute PCR Clean-up Kit (Sigma-
Aldrich) and submitted for sequencing (Source Bioscience) using
primer M13F. DLA analysis and allele assignment was performed
using SBT Engine version 2.17 (GenDx). Haplotype frequencies were
compared between groups using Fisher’s exact test (Monte Carlo
method) in SPSS (PASW Statistics 18, IBM).
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Fourteen DLA haplotypes were identified (12 in pet Beagles and
eight in laboratory Beagles). Only four haplotypes occurred at a fre-
quency >0.05 in each group and three of these more frequent
haplotypes were the same in both groups (Table 1). Whilst some
overlap existed in haplotypes between the two groups, the labo-
ratory Beagle group demonstrated a significant difference in DLA
haplotype frequencies compared with pet Beagles (P < 0.01). More
pet Beagles were homozygous (frequency = 0.45) than laboratory
Beagles (frequency = 0.21; χ2 = 11.93; P < 0.001). Pet Beagles were
predominantly homozygous for haplotype DLA-DRB1*001:02–
DQA1*001:01–DQB1*002:01 (frequency = 0.70 of homozygous pet
Beagles; n = 43).
These results show that the laboratory Beagles had a different
DLA profile, compared with the pet Beagles. Founder effects, selec-
tive breeding within a closed gene pool and use of popular sires have
had an impact on genetic diversity within pedigree breeds
(Lindblad-Toh et al., 2005; Calboli et al., 2008). The difference
between these populations could be the result of selective breed-
ing practices, since the groups have been bred for different purposes
and likely represent subpopulations from historical Beagle stock with
distinct founders (Kennedy et al., 2002b).
Neither group represents the DLA diversity in the dog popula-
tion as a whole, where some breeds (e.g. Jack Russell terrier) express
a more varied DLA profile, whereas others (e.g. Rottweiler) are even
more restricted (Kennedy et al., 2007a). The limited diversity of DLA
types could influence vaccine responses in Beagles and a product
tested in Beagles will not necessarily perform similarly in other dog
breeds.
Both groups were relatively restricted in DLA haplotype diver-
sity. Whilst this restriction is not as marked as for some breeds, such
as the Rottweiler, where only four haplotypes have been identi-
fied (Kennedy et al., 2002a), it is likely to affect the repertoire of
peptide epitopes presented to CD4+ T cells upon antigenic stimu-
lation. Since some haplotypes are only represented in a small number
of Beagles, there is a risk that their frequency may diminish in sub-
sequent generations if breeding strategy is not considered within
a closed colony.
There was a significant difference in DLA homozygosity between
groups. Without pedigrees or breeding strategy information, we can
only hypothesise that this high frequency of homozygosity within
the pet Beagles might indicate a higher degree of inbreeding and/
or a potential dominant sire effect. Homozygosity appears to vary
between dog breeds, depending on the size of the population base;
a previous study found 28.4% homozygosity across breeds (Kennedy
et al., 2002a).
Laboratory Beagles represent a different immunogenetic pool
comparedwith pet Beagles. Theymay be a suitable choice for vaccine
studies if genetic diversity and heterozygosity can be maintained
by strategic breeding. However, laboratory Beagles do not express
the full range of DLA haplotypes and thus are not representative
of the diversity seen within the pet dog population as a whole. This
poses potential problems for the use of any one breed in vaccine
studies, since DLA type could influence responses to antigenic chal-
lenge. MHC class II heterozygosity in humans has been associated
with enhanced resistance and more effective clearance of patho-
gens (Thursz et al., 1997; Carrington et al., 1999). Further studies
are needed to investigate the impact of DLA genotype on suscep-
tibility to infectious disease and response to vaccination in dogs.
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